Notice of Reduction in the Amount of Share Capital and Disposal of Other Capital Surplus 2022/08/23 Notice Read
Notice of exclusive license agreement for artificially modified nucleic acid technology with Takeda Pharmaceutical Company Limited 2022/02/24 Notice Read
Achieved milestonesbased on the technology license agreement with Aligos Therapeutics. 2021/12/10 Notice Read
Notice: Result of mid-term evaluation of the Spinal Cord Injury (SCI) Program of Cyclic Innovation for Clinical Empowerment (CiCLE) supported by Japan Agency for Medical Research and Development (AMED) 2021/04/13 Notice Read
We got a prize in a presentation contest “Innovation Prize” sponsored by Boehringer Ingelheim Japan. 2020/09/23 Notice Read
